715nok
0,0 %
Date:2024-07-24Time:17:30:00Latest report:Q4-2023List:Oslo GrowthTicker:EXTX
Market Cap:229 mnokEnterprise Value:184 mnokNet Sales:- mnokEarnings:-48,3 mnokEmployees:0ISIN:NO0010852213

Ratios

10-year key figure history for EXACT Therapeutics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for EXACT Therapeutics with index and moving average MA50 and MA200.

Stockprice:7,15
MA50:7,53
MA200:10,04
Price/MA200:-28,8 %
RSI (14):47,5
Price/MA50:-5,1 %

Description

EXACT Therapeutics is a Norwegian biotechnology company at a clinical stage that is developing a technology platform for targeted treatment improvement - Acoustic Cluster Therapy. ACT sonoporation is a unique approach to ultrasound-mediated targeted enhancement of therapeutic treatments with the potential to significantly enhance the clinical benefit of a wide range of medications across a range of diseases, including cancer, infectious diseases and neurological diseases.

Medical Equipment